Welcome message from the Organizing Committee
Welcome to ISMA-RHINA 2024 – Unveiling New Frontiers in Allergology
Greetings from ISMA-RHINA 2024! As we gather in the vibrant city of Helsinki, we are thrilled to welcome you to an event that promises to unravel the latest frontiers in the dynamic realm of allergology.
In the past decade, molecular allergology has evolved into a transformative force, significantly impacting allergy diagnosis and allergen immunotherapy. The intricate link between allergen molecules and allergic phenotypes, along with their role as biomarkers for immunotherapy and key contributors to food allergy diagnostic algorithms, has redefined the landscape. Technological innovations, such as microarray and multiplex technologies, coupled with revolutionary techniques for simultaneous single-cell analyses, have ushered in an era of unprecedented research opportunities often referred to as the era of “big data.”
ISMA stands as the premier platform for discussing the newest developments in molecular allergology and understanding their far-reaching implications for allergy diagnosis and therapy.
RHINA, an interactive interdisciplinary EAACI Focused Meeting, has been meticulously crafted to facilitate clinical, scientific, and bench-to-bedside discussions among clinicians, scientists, and industry colleagues. This focus meeting is a catalyst for scientific collaborations, aiming to seamlessly translate emerging discoveries in ENT, Allergen Immunotherapy (AIT), and biologicals in upper respiratory disciplines into tangible benefits for our patients. Challenges in clinical practice, disease mechanisms, advances in novel therapeutics, regulatory issues, and EAACI guidelines will take centre stage at ISMA-RHINA 2024, showcasing an interdisciplinary collaborative approach from the EAACI ENT section, Immunotherapy Interest Group (ITIG), Biologicals Working Group, Asthma, and Immunology sections.
ISMA-RHINA 2024 brings together a diverse assembly of clinicians and scientists, ranging from junior researchers to key opinion leaders, in a focused meeting dedicated to the myriad aspects of upper, lower airway, and ocular diseases. We extend a warm welcome to speakers and participants from across the globe, inviting you to share your knowledge, engage in enriching discussions, and contribute to a truly interactive interdisciplinary dialogue.
Let’s embark on this exciting journey together at ISMA-RHINA 2024, where we collectively shape the future of allergology.
Welcome message from VP Congresses
Dear EAACI Friends,
We are delighted to extend an invitation to the prestigious ISMA-RHINA 2024 event, set to take place onsite in the captivating city of Helsinki. Following the success of our Digital 2022 joint meeting, this edition promises to be an exclusive gathering of experts in molecular allergology and rhinallergy.
ISMA-RHINA 2024 will continue the tradition of bringing together internationally renowned specialists to explore the latest advancements in molecular allergology, focusing on their profound implications for allergy diagnosis and therapy. Simultaneously, the European Rhinallergy Meeting will provide a platform for medical professionals, doctors, researchers, and allied healthcare experts to engage in discussions on cutting-edge science related to allergy and immunology of the upper airways, employing a translational “bench to bedside” approach.
Our collaborative effort across various research domains within ISMA and RHINA ensures that delegates will have a unique opportunity to attend a high-level meeting. The event will feature lectures that showcase the most up-to-date knowledge and best practices in molecular allergology, rhinallergy, and related areas. The focus remains on fostering scientific collaborations and facilitating the seamless translation of emerging discoveries into clinical practices that ultimately benefit patients.
ISMA-RHINA 2024 will be an onsite-only event, providing an immersive experience for all attendees. Join us in Helsinki for an enriching experience, where the highest standards of care will be shared and implemented within our specialties.
We eagerly anticipate your participation at ISMA-RHINA 2024 and look forward to seeing you in Helsinki!
EAACI Vice-President Congresses
Potential Conflict of Interest Declaration
The European Academy of Allergy and Clinical Immunology (EAACI) takes pride in offering scientific events of the highest standard. In accordance with UEMS criteria EAACI dutifully requests all committee and faculty members to declare any conflict(s) of interest.
Milena SokolowskaISMA-RHINA 2024 Chair
Sanna Toppila-SalmiISMA-RHINA 2024 Chair
Valérie HoxISMA-RHINA 2024 Co-Chair
Barbara BohleISMA-RHINA 2024 Co-Chair
Edward KnolISMA-RHINA 2024 Co-Chair
Heimo BreitenederISMA-RHINA 2024 Co-Chair
Inge KortekaasISMA-RHINA 2024 Co-Chair
Ludger KlimekISMA-RHINA 2024 Co-Chair
Philippe GevaertISMA-RHINA 2024 Co-Chair
Mohamed ShamjiEAACI Vice-President Congresses